We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Modifying Brain's Immune Response to Kill Tumors

By Biotechdaily staff writers
Posted on 17 Apr 2006
Virologists have discovered why avian flu has so far failed to spread from person to person despite being able to flourish in human lung tissue: a lack of receptors to bind to the virus.

Investigators at the University of Wisconsin (Madison, USA; www.wisc.edu) worked with cultures of human cells taken from various portions of the respiratory track. More...
By monitoring the ability of the virus to bind to the cells, they were able to show that cells from the upper portions of the respiratory system lacked surface receptors for binding to the avian H5N1 virus. They reported in the March 23, 2006, issue of Nature that avian flu requires a binding site for sialic acid linked to galactose by an alpha-2,3 linkage, while human influenza virus requires an alpha-2,6 linkage.

"Deep in the respiratory system, (cell) receptors for avian viruses, including avian H5N1 viruses, are present,” explained senior author Dr. Yoshihiro Kawaoka, professor of pathobiologic sciences at the University of Wisconsin. "But these receptors are rare in the upper portion of the respiratory system. For the viruses to be transmitted efficiently, they have to multiply in the upper portion of the respiratory system so that they can be transmitted by coughing and sneezing. No one knows whether the virus will evolve into a pandemic strain, but flu viruses constantly change. Certainly, multiple mutations need to be accumulated for the H5N1 virus to become a pandemic strain.”



Related Links:
University of Wisconsin

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Electrolyte Analyzer
CBS-4000 (CBS-400)
Manual Pipetting Aid
Pipette Controllers macro
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image Credit: iStock

Blood Test Measuring Tumor Proliferation May Guide Treatment Sequencing in Metastatic Melanoma

Metastatic melanoma remains difficult to manage because outcomes vary widely and early prognostic markers are limited. About half of patients carry a BRAF gene mutation, giving clinicians several first-line... Read more

Molecular Diagnostics

view channel
Image Credit: Adobe Stock

Comprehensive Genomic Testing Expands Treatment Options for Advanced Cancers

Selecting effective therapies for advanced cancers remains difficult because standard tumor testing often targets only a limited set of genes. As options dwindle, many patients face decisions without strong... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.